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Rats depleted of dopamine (DA) by intraventricular 6-hydroxydopamine (6-OHDA) in infancy show behavioral impairments as adults, but 
their basic sensory-motor functions and feeding abilities are intact; at least relative to the pronounced deficits seen in rats given similar treatment 
in adulthood. Here we investigate whether presynaptic changes culminating in enhanced DA release are present in adult rats that received 
neonatal damage, and whether these are of a sufficient magnitude to contribute to the sparing of function. We used microdiatysis in rats during 
the resting state, walking on a treadmill, and after a systemic injection of amphetamine. It was found that neonatal 6-OHDA produced a nearly 
complete (<1% of control) depletion of DA in postmortem tissue, but this was not accompanied by a comparable decline in the basal 
extracellular concentrations of DA, which were only reduced by 12-54% of control values. In contrast, the extraceUular concentrations of DA 
metabolites were greatly reduced, reflecting the post-mortem tissue concentrations of DA. Nevertheless, neonatally depleted animals were 
markedly deficient in their ability to respond to an amphetamine challenge, both behaviorally and in their ability to further increase DA release. 
Thus, following neonatal DA depletion there appear to be extensive changes in the few remaining DA terminals that are sufficient to maintain 
relatively high extracellular (and presumably synaptic) concentrations of DA during the resting state, but the capacity of the remaining DA 
neurons to respond to increased demand is very limited. This presynaptic compensatory response may play a role in the sparing of behavioral 
function seen following neonatal damage. 
INTRODUCTION 
The behavior  of rats deple ted  of dopamine  ( D A )  in 
infancy is very different  than the behavior  of rats 
dep le ted  of D A  in adul thood.  Extensive damage to the 
neostr ia ta l  D A  system in adult  rats produces  a syndrome 
that  is similar to Parkinson 's  disease in humans 25'37. The 
rats display bradykines ia ,  sensor imotor  neglect,  aphagia,  
adipsia,  short-s tep locomot ion ,  akathisia,  excessive brac- 
ing and clinging react ions and cognitive dysfunction 24 
34,35,46.50,52,54,58.59. Extensive damage to the mesostr iatal  
D A  system in neonata l  rats produces  regula tory  deficits, 
and impai rments  in some aspects of motor  behavior ,  
sensory responsiveness,  and cognitive function, but o ther  
behaviors  are much less affected than in rats deple ted  of 
D A  in adu l thood  6"8'9"41'53. Funct ions that are relat ively 
spared  in neonates  include spontaneous  locomotor  activ- 
ity, the abil i ty to ingest dry food and water ,  and to orient  
to certain forms of sensory st imulat ion 7~2"33. In fact, 
neonata l ly  dep le ted  rats are hyperkinet ic  ~2'29, which 
contrasts  marked ly  with the paucity of spontaneous  
locomotor  activity seen in adult  dep le ted  rats. This has 
led some workers  to suggest that  neonata i ly  dep le ted  rats 
are more  representa t ive  of an animal  model  of minimal 
brain dysfunction than of  adult Parkinsonism 29'~). 
In adult  animals D A  deplet ion is accompanied  by a 
number  of compensa to ry  neural  responses that  are 
thought to contr ibute  to the recovery of function char- 
acteristic of D A -de p l e t i on  syndromes  23. Presynaptic  
changes,  including an increase in the synthesis,  metabo-  
lism, and fractional  release of D A  occur after even 
modera te  damage.  For  example ,  using rats with a 
unilateral  D A  deple t ion ,  Robinson and Whishaw 31 
showed that the extracel lular  concentra t ions  of D A  in the 
damaged  hemisphere  were much higher than would be 
predicted by the extent  of the D A  deple t ion  measured  in 
pos t -mor tem tissue. It has been suggested that  these 
presynapt ic  compensa to ry  responses may be largely 
responsible for the rapid  recovery and sparing of function 
seen after part ial  lesions in adults 2"4"m'21"3t"43"56. If the 
deplet ion of striatal D A  exceeds about  80-90% there is 
also an increase in the number  of postsynapt ic  D A  
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receptors (receptor supersensitivity). A combination of 
pre- and post-synaptic changes is thought to be largely 
responsible for the recovery of function that occurs 
subsequent to extensive D A  depletion t°'14'26'27'49. 
The neural mechanisms that contribute to the sparing 
of function seen in rats depleted of D A  as neonates have 
received much less attention. Nevertheless, the earlier 
report of Robinson and Whishaw 3~ raises the possibility 
that in neonatally depleted rats the remaining DA 
terminals may be sufficiently active to produce a func- 
tionally adequate supply of extracellular DA,  and that 
this contributes to sparing of function. The purpose of the 
present study was to determine if this is the case by 
directly measuring the extracellular concentrations of DA 
in the striatum, by use of intracerebral microdialysis in 
adult rats treated with 6-hydroxydopamine (6-OHDA) as 
neonates. This was done under a variety of behavioral 
conditions, including the resting state, walking on a 
treadmill and after a systemic injection of amphetamine. 
The post-mortem tissue concentrations of D A  were also 
determined to estimate the magnitude of the lesion, and 
for comparison with the extracellular concentrations of 
D A  measured in vivo. 
M A T E R I A L S  A N D  M E T H O D S  
Overview of the protocol 
Rats  were given intraventricular 6 - O H D A  or saline injections on 
day 3 post -par tum.  At  27 days of age they were weaned,  removed 
from the sawdust-f loored materni ty cages,  and housed in pairs in 
wire mesh  hanging cages. Thereafter ,  they were weighed and 
handled weekly. Formal testing (see below) began when the rats 
were 6 months  of age and included the following: (1) measurement  
of spon taneous  activity in photocell-based activity monitors for 24 
h (13.00-13.00 h); (2) stereotaxic surgery for the implantation of a 
microdialysis probe, and starting at least 18 h later dialysate was 
collected during 3 conditions - -  the baseline resting state, during 
walking on a treadmill and then after an injection of amphetamine ;  
(3) after all of  the rats had been tested they were decapitated and 
pos t -mor tem tissue samples were obtained for subsequent  biochem- 
ical analysis. 
Subjects 
The subjects were 10 malc and 111 female L o n g - E v a n s  (University 
of Lethbridge Vivarium) rats obtained from 4 litters culled to 5 rats 
each. They werc housed on a 14:10 h l ight-dark cycle (lights on 
I18.00 h), and with free access to food and water. Five male and 5 
female rats received 6 - O H D A  as neonates  and the remaining 10 
animals received control surgery. 
Test chambers 
Spontaneous  locomotor activity was tested in photocell activity 
monitors  constructed from wire-hanging cages. The individual cages 
were 40 cm long, 25 cm deep and 14 cm high, with two parallel 
horizontal infrared beams 1 cm above the floor, 34 cm apart, and 
perpendicular  to the long axis of the cage. The total number  of 
crosses between the two photocells,  registered incrementally each 
hour  by an Apple 1I+ computer ,  was used as an index of activity. 
The computer  was p rogrammed in such a way that a rat had to 
activate each photocell in succession in order to register a count. 
Therefore ,  activity counts represent  locomotion from one side of the 
cage to the other  ( 'crossovers ') .  
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During the dialysis procedure,  rats were placed in a Plexiglas test 
chamber  that was 31 cm wide x31 cm deep ×35 cm high. Each 
chamber  had a woodchip-covered floor, and provided access to both 
food and water. The activity of the animals  in the test chamber  was 
moni tored via a color camera  at tached to a Sony SI, 2500 video 
recorder.  
Forced locomotion was achieved by placing the rats in one of two 
14 cm wide x36 cm long ×33 cm high Plexiglas boxes mounted  on 
a conveyor belt, which was driven at a speed of 300 cm/min.  
Surgical procedures 
Neonatal dopamine depletion. On day 3 post-par tum the pups 
were anesthet ized with cold by placing them in a - 5  °C controlled 
envi ronment  15 min prior to surgery,  and they were then randomly 
assigned to the t rea tment  or control group. Fifteen min prior to 
cooling the rats were administered d ismethyl imipramine  (25 mg/kg, 
s.c. in the neck), an inhibitor of norepinephr ine  uptake,  which has 
been shown to reduce the toxic effects of 6 - O H D A  on noradren- 
ergic nerve terminals s. The pups were then placed in a head holder,  
the skull was exposed,  and the pups received either 10 ul of the 
vehicle solution (1t.9% sodium chloride and (I. 1% ascorbic acid) or 
10 u[ of the 6 - O H D A  solution (vehicle plus 150 ug  6 - O H D A ,  free 
base, Sigma). Half  of the injection was given in the right lateral 
ventricle and half of the injection was given in the left lateral 
ventricle, over 3 min each (coordinates,  anterior to bregma 0.5 mm,  
lateral to the midsagittal fissure 1.5 mm and ventral to the skull 
surface 2.5 mm;  see Whishaw ct al. ~ for details). 
Dialysis probe implants. On the day prior to microdialysis the 
animals were anesthet ized with sodium pentobarbital  (30-35 mg/kg, 
i.p.) and a dialysis probe stereotaxically placed into the corpus of 
the str iatum on either the left or right side, with the side chosen 
randomly.  The dialysis probe (see below) was connected to a 1.(I ml 
gastight Hamil ton llll)(I series syringe mounted  on a syringe pump 
(Harvard Appara tus  Model 22), and a modified Ringer solution 
(147 mmol Na +, 2.3 mmol Ca +, 4 mmol  K '  and 155.6 mmol CI , 
pH 6.0) pumped through the probe at a rate of I 2 ul /min during 
the entire surgical procedure.  (All solutions were filtered with 0.2 
u m  syringe filters.) The entire assembly was held in place by 
enclosing it in dental  cement ,  and it was fixed to the skull with 
stainless-steel screws. The animals were then placed mto the test 
chamber  and left there overnight ,  with the Ringer solution being 
pumped through the probes at (I. 15 ul /min during this time. Testing 
began the next day between (18.00 and 10.00 h, at least 18 h after 
probe implantat ion (see below). 
Construction of the dialysis probes 
The dialysis probes were similar to those described previously by 
Robinson and Whishaw ~ . The inlet tubing, which was connected to 
one channel of a 2-channel liquid swivel (Harvard Bioscience), 
consisted of an approximately 60-cm length of Intramedic PE-2t) 
tubing (Cole-Palmer).  The other cnd of thc PE-20 tubing was 
connected to a section of 26-gauge stainless-steel tubing, which 
previously had been prepared as follows. An approximately Ill mm 
long piece of regenerated cellulose hollow fiber dialysis tubing was 
cemented  into the distal end of the stainless-steel tubing with 2-Ton 
clear epoxy (Devcon).  After  the junction was dry to the touch (a few 
hours) the dialysis fiber was t r immed to 4.25 mm,  the tip sealed with 
epoxy (0.25 mm thick dollop), and then left to dry overnight.  The 
dialysis fiber (Spectra/Por; Spectrum Medical) had a nominal 
molecular weight cut-off of 5000-6000, an i.d. of 215 /an ,  and a wall 
thickness of 18 felt1 (o.d. 233 /an) .  The outlet tubing consisted of 
a 5ll-cm length of flexible fused silica capillary tubing with an o.d. 
of 15()/tm and i.d. of 75 u m  (Polymicro Technologies),  The capillary 
tubing was incorporated into the probe by slipping it through the 
26-gauge stainless-stcel cannula and into the dialysis chamber  via a 
small hole pierced through the inlet tubing with a 30-gauge needle. 
The entire upper portion of the assembly,  including the junction 
between the inlet tubing and stainless steel cannula ,  and the area 
where the outlet tubing pierccd the inlet tubing, was scaled with a 
coating of 2-Ton epoxy. After  the epoxy had cured probcs were 
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stored dry, suspended in air and protected from dust. 
Measurement of probe recovery in vitro 
At least 2 days prior to implantation all probes were flushed 
thoroughly. The flushing procedure consisted of pumping filtered 
high-performance liquid chromatography (HPLC) grade water 
through the probes, initially at 1-2/A/min. For the first 20 min the 
dialysis tips were placed in a beaker containing 70% ethyl alcohol 
(to remove the isopropyl myristate with which the fibers are 
originally filled). Next, the tips were placed in HPLC water and the 
probes left to flush overnight at approximately 0.5/d/min. The next 
day, the water was removed from the probes by gentle suction with 
the attached syringe and they were filled with freshly prepared 
filtered Ringer solution. The Ringer solution was pumped through 
the probes at 1.5/d/rain, with the dialysis tips in a beaker containing 
Ringer solution. After at least 30 min the beaker of Ringer was 
replaced with a beaker containing Ringer plus 200 pg/ml of DA, its 
metabolites dihydroxyphenylacetic acid (DOPAC) and homovanil- 
lic acid (HVA) and the serotonin (5-HT) metabolite 5-hydroxyin- 
doleacetic acid (5-HIAA) (plus 1 mg ascorbate/100 ml), which was 
maintained at 37 °C in a water bath. After waiting 20 rain, two 
10-min dialysis samples were collected and the dialysate assayed by 
HPLC with electrochemical detection (HPLC-EC). Recovery was 
calculated for each probe as described previously 3~~t, and the 
average of two samples used. 
In vivo microdialysis procedures 
The inlet and outlet tubing were threaded through the lumen of 
a coiled steel tether, attached to a dental acrylic post on the animal's 
head, and attached to a liquid swivel (Harvard Bioscience). The 
dialysate was collected in minivials that were attached to the tether, 
about 35 cm above the animal, Thus, collection vials could be 
quickly exchanged without touching the animal or impeding its 
movement. 
On the morning of a test day the pump speed was set at t.5 
/A/rain, and after at least 30 min, dialysate samples were collected. 
At least 5 baseline samples were collected over 20-50-min intervals. 
Samples were stored on ice for short periods, but all were assayed 
within 30 min of collection. After baseline samples were collected 
and assayed, the animals were placed onto the conveyor belt where 
they walked for 1 h. During this time 3 more 20-min samples were 
taken. At the end of the walking test, the animals were returned to 
the holding boxes and given a subcutaneous injection of 1.5 mg/kg 
of o-amphetamine sulfate (weight of the salt) in the neck. After this, 
7 more samples were collected over 20-min intervals. 
Behavior was videotaped and subsequently analyzed by viewing 
the videotapes at 2 times normal speed. Behaviors scored were 
number of rears and the number of times the midline of the box was 
crossed. 
Assay of dialysate 
Dialysis samples were assayed by HPLC with series oxidative- 
reductive electrochemical detection (HPLC-EC), and on a system 
used exclusively for dialysate. No more than 45/A of dialysate was 
injected directly on the column, with no pretreatment, via a 
Rheodyne injection valve with a 100-/~1 sample loop. The column 
was a 15 cm long Chromatography Sciences Company ODS-2 
reverse-phase column (C-18; 5-~m particles 0.46 cm i.d.). The 
mobile phase contained 0.06 M NaPO4, 0.03 M citric acid, 0.1 mM 
EDTA, 20% methanol and 0.0936 mM sodium dodecyl sulfate, at 
an apparent pH of 3.35. A Model 414 Kontron single piston HPLC 
pump was used to deliver dialysate samples to the column. The 
HPLC-EC system consisted of an ESA Model 5100A Coulochem 
Detector with a Model 5011 High Sensitivity Analytical Cell. A 
Model 5021 Conditioning Cell was positioned after the column but 
before the two analytical electrodes and was used to oxidize at + 100 
inV. The first analytical electrode oxidized at +340 mV (gain 100. 
filter setting 4) and was used to quantify DOPAC, HVA and 
5-HIAA. The second analytical electrode reduced at -230 mV (gain 
8500, filter setting 10) and was used to quantify only DA. Under 
these conditions DA eluted relatively late, lollowing DOPAC, 
5-HIAA and HVA, and was usually separated from HVA by 2-3 
min. The total run time was 8-10 rain. Some sensitivity was lost 
because DA eluted so late, but because DA metabolite concentra- 
tions in dialysate are typically about 100 times greater than DA, it 
was found that the advantages of keeping DA well away from the 
metabolites outweighed the disadvantages. 
Signals were recorded with a Linear t200 dual pen recorder (10 
mV full scale pen deflection), and the amount of each compound 
determined by comparison with the peak height of standards run 
with each assay (4 pg//A of DA and 200 pg//d of DOPAC, HVA and 
5-HIAA). 
Assay of brain tissue 
Tissue samples of anterior medial striatum, nucleus accumbens, 
and medial frontal neocortex were assayed for DA, DOPAC, HVA, 
norepinephrine (NE), 5-HT and 5-HIAA. At the end of the 
experiment the tubing leading to the dialysis probe was severed at 
the level of the dental cement 'cap', the open ends were sealed with 
epoxy, and the animal was returned to its home cage. At least 5 days 
later each animal was subsequently killed by decapitation and its 
brain rapidly removed and placed in ice-cold saline. After the brain 
cooled (30-45 s) it was placed in a chilled cutting block and brain 
slices obtained as described by Heffner et alfl 7. The slices were 
immediately examined and the approximate location of the 'track' 
formed by the dialysis probe was noted. The left and right striatum, 
nucleus accumbens, and medial frontal neocortex were then 
dissected out free-hand, weighed, and placed into individual tubes 
containing 0.05 N perchloric acid and dihydroxybenzylamine (in- 
ternal standard). The samples were homogenized and centrifuged at 
1500 g for 4 rain. The supernatant was assayed by HPLC-EC, using 
procedures similar to those described previouslym 
Data analysis 
Dialysate values are reported as fmol/min, after correcting for 
probe recovery. Baseline values represent 20-50-min samples. The 
average (___ S.E.M.) relative recovery values for the probes used 
were: DA 25.30 + 1.00%; DOPAC 25.41 _+_ 0.79%; HVA 23.99 _+ 
0.79%; and 5-HIAA 27.45 + 1.07%. Analyses of variance, t-tests, 
and correlation coefficients were performed using standard statis- 
tical packages. 
RESULTS 
Ac t iv i t y  m e a s u r e m e n t s  a n d  t i s sue  assays  w e r e  o b t a i n e d  
for  all 20 ra ts ,  bu t ,  b e c a u s e  of  t e c h n i c a l  dif f icul t ies ,  
i n c o m p l e t e  dia lysis  resu l t s  w e r e  o b t a i n e d  f r o m  3 c o n t r o l  
ra ts  a n d  2 D A - d e p l e t e d  ra ts .  T h u s ,  for  t he  dia lysis  
m e a s u r e s ,  r e su l t s  a re  r e p o r t e d  fo r  15 rats .  F u r t h e r m o r e ,  
5 - H I A A  was q u a n t i f i e d  in t he  d i a lysa t e  of  o n l y  5 con t ro l  
ra ts  a n d  5 D A - d e p l e t e d  rats .  
Post-mortem tissue measures and probe placement  
A s u m m a r y  of  t he  a v e r a g e  p o s t - m o r t e m  t i ssue  va lues  
for  6 - O H D A - t r e a t e d  a n d  c o n t r o l  a n i m a l s  is g iven  in 
Tab le  I. T h e r e  w e r e  n o  s ign i f i can t  l e f t / r igh t  a s y m m e t r i e s ,  
so the  va lues  f r o m  the  two  s ides  w e r e  p o o l e d  for  
s ta t i s t ica l  c o m p a r i s o n s .  Al l  of  t he  6 - O H D A - t r e a t e d  ra t s  
h a d  e x t e n s i v e  b i l a t e r a l  s t r i a t a l  d o p a m i n e  d e p l e t i o n s  
( r a n g e  0 . 9 2 - 0 . 3 3 %  of  t he  c o n t r o l  m e a n ) .  In a d d i t i o n ,  
n e o c o r t i c a l  D A  was  r e d u c e d  to 7 0 % ,  a n d  n u c l e u s  
a c c u m b e n s  D A  to 8 . 1 %  of  t he  c o n t r o l  va lues .  D O P A C  
c o n c e n t r a t i o n s  w e r e  a lso s ign i f ican t ly  d e c r e a s e d  in b o t h  
TABLE I 
Mean (ng/mg +_ S. E.M.) concentrations of the catecholamines, 5-HT and their metabolites in post-mortem tissue samples obtained from the medial 
frontal neocortex, striatum, and nucleus accumbens of neonatal 6-OHDA lesion (n = lO) and control (n = 101 groups 
n.d., not detectable. 
DA D O P A C  HVA NE 5-HT 5-HIAA 
Control 
Cortex 0.11 (0.01) 0.04 (0.00) 
Striatum 14.88 (0.42) 1.36 (0.04) 
Accumbens 6.75 (0.53) 2.10 
Lesion 
Cortex 0.08 (0.01)* /I.04 
Percent 69.7 93.3 
Striatum 0.10(0.011" 0.03 
Percent 0.7 2.4 
Accumbens 0.54(0.11)* 0.15 
Percent 8.1 7.2 
*P<0.05. 
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n.d. 0.45 (0.02) 0.91 (0.07) 11.31 (11.02) 
0.78 (0.04) 0.10 (0.005) 0.82 (0.05) 0.48 (0.02) 
(0.11) 0.66(0.04) 0.21 (0.04) 0.82(1t.13) 0.54(0.05) 
(0.01) n.d. 0.49 (0.02) 1.31 (0.26) 0.33 (0.02) 
108.5 143.9 108.5 
(0.003)* n.d. 0.07 (0.01)* 2.50 (0.28)* 11.96 (1t.061" 
68.2 3116.9 201.2 
(0.02)* n.d. 0.39(0.12) 1.11 10.14)  0.68(0.05)* 
182.7 136.1 125.7 
the s t r ia tum and nucleus accumbens,  and H V A  was 
below the detect ion limits of the assay in 6 - O H D A  
t rea ted  rats (see Table I). Whereas  NE was slightly, but 
not significantly, higher  in the cortex and nucleus 
accumbens ,  it was reduced to 68% of control  in the 
s t r ia tum (t-test,  P < 0.05). In contrast  to the catechol-  
amines,  5-HT and 5 - H I A A  were e levated in all samples 
ob ta ined  from the 6 - O H D A - t r e a t e d  group,  and in the 
case of the striatal  samples were 307% and 201% of the 
control  values,  respectively (t-tests, P < 0.05). 
The dialysis probes  were all located within the corpus 
of the neos t r ia tum centered  around the coronal  plane 
located 0.8 mm anter ior  to bregma in the Paxinos and 
Watson 2s atlas. Individual  probes  varied by _+0.5 mm 
along the an t e r i o r -pos t e r i o r  axis. The dialysis tips ranged 
from 2 to 3 mm lateral  to the midline in the m e d i a l -  
lateral  plane,  and ex tended  through the entire dorsal- 
ventral  extent  of the s t r ia tum (i.e. for about  4 mm ventral  
to the corpus callosum).  
General  behavioral  observations and noctural  activity 
The neonata l ly  dep le ted  rats were able to sustain 
themselves  on dry food and water ,  locomote  seemingly 
normally,  and orient  to tactile stimuli such as touches 
from cot ton- t ipped  probes  inserted into their  cages. They 
were impai red  in eat ing efficiently, however ,  in that  male 
rats were 35.5% lighter (545.2 vs 351.4 g, t 8 = 5.49, P = 
0.0006) and female rats were 28.5% lighter (308.6 vs 
220.6 g, ts = 3.35, P = 0.01) than their  respective control  
groups.  They were also hyperact ive when handled,  
tending to jump  and squeal when lifted from their  cage. 
Af t e r  being placed in the activity cages for measure-  
ment  of overnight  activity, the D A - d e p l e t e d  rats were 
initially more  active than the control  rats (P  < 0.001 ; Fig. 
1). They also displayed high levels of activity relat ive to 
the control  rats during the dark por t ion of the l igh t -da rk  
cycle (P  < 0.001). Finally,  during the light por t ion of the 
day-light cycle on the second day,  the DA-dep l e t ed  
group was slightly, al though significantly (P < 0.001), 
less active than the control  rats. 
Behav ior  during dialysis 
All animals were habi tua ted  to the test chamber  for 2 
days prior  to implanta t ion of dialysis probes .  They 
received further  habi tuat ion  by being left overnight  in the 
test room,  and during the next l ights-on period.  During 
this t ime the lights were on and background  noise was 
provided  by a radio tuned to a ' country  and western '  
station. Therefore ,  they were general ly inactive during 
baseline sample collection,  somet imes  falling asleep. The 
frequency of crossovers ( locomot ion)  and rearing were 
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Fig. 1. Average (+_ S.E.M.) activity counts (i.e. locomotion from 
one end of the cage to the other) in control and neonatally depleted 
rats during a 24-h test. Lights were off between 20.00 and 08.00 h. 
Control, n = 10; lesion, n = 10. An overall analysis of variance 
resulted in a significant effect of group (Fk~ ~ - 13.03, P = /I.002), 
of time (F23.~14 = 8.58, P < 0.001) and a significant group by time 
interaction (F23,414 = 4.48, P < 0.001). Subsequent Tukey tests 
confirmed significant group differences during the period of time 
prior to lights off, during the lights off period and after lights came 
back on. 
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20-min interval during the resting state (Fig. 2). There 
were no differences between the control  and DA- 
dep le ted  groups in numbers  of crosses (control = 4.8 _ 
2.48 vs D A - d e p l e t e d  = 2 + 0.9, t i t  : 1.02, P -- 0.32) or 
rears (control = 0.8 + (1.3 vs D A - d e p l e t e d  = 1.6 _+ 0.7, 
t17 = 1.09, P = 0.29). 
Animals  in both groups walked well when placed on 
the conveyor  belt.  Throughout  the test,  however,  rats in 
the D A - d e p l e t e d  group were more  energetic,  staying 
away from the back wall of the conta iner  in which they 
walked.  Rats  in the control  group frequently walked with 
their  backs abut ted  to the rear  wall of the restraining box, 
and they occasionally had to be pushed away from the 
wall. 
In contrast ,  amphe tamine  produced  a much greater  
increase in locomot ion  and rearing in the control  animals 
than in the neonata l ly  dep le ted  animals (Fig. 2). In fact, 
amphe tamine  did not produce  a significant change in 
crosses or  rears in the D A - d e p l e t e d  animals. 
Extracellular DA and DA metabolites 
Fig. 3 i l lustrates the average extracel lular  concentra-  
tions of  D A ,  D O P A C  and H V A  during rest,  t readmil l  
walking and after  amphe tamine ,  as es t imated by the 
levels of these compounds  in dialysate (i.e. dialysate 
values were correc ted  for probe  recovery).  
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T i m e  (20-mln Intervals)  
Fig. 2. Average (+ S.E.M.) number of crosses between two halves 
of the holding cage (top) and rears (bottom) during baseline 
(interval number 1) and after amphetamine (1.5 mg/kg s.c.) 
treatment (intervals 2-8). Control, n = 7, lesion, n = 8. Analyses 
of variance showed that amphetamine produced a significant 
increase in both locomotion and rearing in control animals (F's --- 
6.06 and 5,99, respectively, P < 0.001), but had no effect on animals 
treated with 6-OHDA as neonates (F's < 1.0). 
The extracel lular  concentrat ions  of IkA are il lustrated 
in Fig. 3 ( top) ,  and an analysis of variance confirmed the 
impression that the control  and neonatal ly  depleted 
groups differed significantly across all 3 test condit ions (1; 
= 35.7, P < 0.001; and follow-up Tukey tests). At  rest. 
the average extracel lular  concentrat ions  of D A  in control 
animals was es t imated to be 14.19 nM, and in neonata l ly  
deple ted  rats it was 4.77 nM, which is 33.6% of the 
control  value. There  was no significant change in extra- 
cellular D A  during treadmil l  walking in ei ther  group,  but 
1.5 mg/kg of amphe tamine  produced  a significant in- 
crease in extracel lular  D A  in both groups. Fig. 4 (top) 
shows the extracel lular  concentrat ions  of D A  for just the 
neonatal ly  dep le ted  animals,  with an expanded  vertical 
scale, to bet ter  i l lustrate the effect of amphetamine  
adminis t ra t ion in these animals.  It is obvious,  however ,  
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Fig. 3. Extracellular concentrations (mean _+ S.E.M.) of dopamine 
(DA, top), 3,4-dihydroxyphenylacetic acid (DOPAC, middle) and 
homovanillic acid (HVA, bottom) collected during 3 behavioral 
conditions: resting, walking in a treadmill and after 1.5 mg/kg 
amphetamine (s.c.) from control and neonatally dopamine-depleted 
rats. Each sample in each condition comprised 20-min collection at 
1.5/fl/min. 
markedly deficient relative to controls (Figs. 3 and 4). 
The extracellular concentrations of the DA metabo- 
iites, DOPAC and HVA, are illustrated in Fig. 3 (middle 
and bottom panels). As with DA, the control and 
neonatally-depleted groups differed significantly across 
all 3 test conditions (F's = 53.3 and 42.3, P < 0.001, 
DOPAC and HVA, respectively). At rest, the average 
extracellular concentrations of DOPAC and HVA in 
control animals were estimated to be 4212.41 and 3476.91 
riM, respectively; and in neonatally-depleted animals 
96.20 and 70.80 nM, respectively. The extracellular 
concentrations of DOPAC and HVA in rats exposed to 
6-OHDA as neonates were, therefore, 2.28% and 2.04% 
of the control values, respectively. There was no signifi- 
cant change in extracellular DOPAC or HVA in control 
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Fig. 4. Extracellular concentrations (mean + S.E.M.) of dopamine 
(DA, top), 3,4-dihydroxyphenylacetic acid (DOPAC, middle) and 
homovanillic acid (HVA, bottom) collected during 3 behavioral 
conditions: resting, walking in a treadmill and after 1.5 mg/kg 
amphetamine (s.c.) from neonatally dopamine-depieted rats. Each 
sample in each condition comprised 20-min collection at 1.5 pl/min. 
Note: the figure represents the data from the lesion group in Fig. 
3 plotted against an expanded y-axis. 
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Fig. 5. Comparison of the tissue content of DA and its metabolites 
at post-mortem analysis and the dialysis content of these substances 
during resting conditions from 8 neonatal DA-depleted rats as a 
percent of control tissue and dialysis concentrations. Extracellular 
DA concentration (Dia-DA) was greater relative to tissue DA levels 
(Tis-DA; t 7 = 5.99, P = 0.0006). In contrast, there was no 
significant difference between dialysate levels (Dia-DOPAC) and 
tissue content (Tis-DOPAC) of DOPAC (17 0.089, P - 0.93). 
Only dialysate levels for HVA (Dia-HVA) are shown because HVA 
was not detectable in the tissue assay. 
metabolites levels rose significantly (P < 0.05, Tukey 
test) during treadmill walking in the neonatally depleted 
group (Fig. 4); although this was a very small effect. 
Amphetamine treatment caused a significant decrease in 
extracellular DOPAC and HVA in both groups (Figs. 3 
and 4). 
Fig. 5 compares the post-mortem tissue levels of DA 
and its metabolites with the extracellular concentrations 
of these compounds in 8 individual neonatally depleted 
rats; with all values expressed as a percent of the 
respective control values. For DA, the post-mortem 
tissue concentrations were less than 1% of control in all 
animals (Fig. 5). In contrast, the extracellular concen- 
trations of DA ranged from a low of 12%, of control to 
a high of 56% of control. Thus, the extracellular 
concentrations of DA were much higher than would be 
predicted by the DA concentrations in post-mortem 
tissue. In contrast, there is a good relationship between 
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Fig. 6. Changes (mean _+ S.E.M.) in 5-hydroxyindoleacetic acid 
(5-HIAA) during 3 behaviors: resting, walking in a treadmill and 
aftcr 1.5 mg/kg amphctaminc (s.c.). Control, n - 5: lesion, n = 5. 
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the post-mortem tissue concentrations of the DA metab- 
olites and the concentrations of these compounds in 
extracellular fluid (Fig. 5). 
The extracellular concentrations of 5-HIAA are illus- 
trated in Fig. 6. As with the post-mortem tissue concen- 
trations of 5-HT and 5-HIAA, neonatally depleted 
animals had higher extracellular levels of 5-HIAA than 
controls (although this difference did not reach statistical 
significance, perhaps because of the low n, F~.s = 2.52, 
P = 0.15). The levels of 5-HIAA were slightly elevated 
in both groups during the walk and amphetamine 
conditions, relative to rest (P < 0.05). 
DISCUSSION 
The major finding in the present study is that the in 
vivo concentrations of DA in striatal extracellular fluid of 
adult freely behaving rats, which received DA-depleting 
lesions at 3 days of age, were substantially higher than 
would be predicted by DA concentrations in post- 
mortem tissue. In rats that received 6-OHDA as neo- 
nates DA concentrations in post-mortem tissue were less 
than 1% of that in controls (range 0.92-0.33% of 
control). In striking contrast, the resting extracellular 
concentrations of DA, estimated from dialysate, ranged 
between 12 and 56% of control. These results suggest 
that some of the functional sparing seen after neonatal 
DA depletion could be due to the ability of the remaining 
DA terminals to maintain relatively high extracellular 
concentrations of DA. 
The neuroplastic adaptations responsible for the ap- 
parent up-regulation of DA release seen following 
damage to DA neurons in neonates have not been well 
characterized, but studies in adults suggest a variety of 
changes probably interact to maintain extracellular DA 
levels 47. For example, after partial damage the remaining 
DA cells greatly increase their rate of DA synthesis : 
3,19.20,56; first by an increase in the affinity of tyrosine 
hydroxylase for its cofactor, and later by an increase in 
the amount of tyrosine hydroxylase ~'57. This enhanced 
synthetic capacity probably contributes to the ability of 
the remaining DA terminals to show large increases in 
fractional DA release in vitro 43, which is consistent with 
the many reports of an increased ratio of DA metabolites 
to DA following partial DA depletion 4"2°'21"38. A 6- 
O H D A  lesion also destroys the DA re-uptake sites on 
DA terminals, leading to a reduction in DA re-uptake, 
and presumably a reduction in the rate that DA is 
removed from the extracellular fluid 44"56. Thus, increased 
DA synthesis, increased DA release and decreased DA 
re-uptake probably all contribute to the relatively high 
extracellular concentrations of DA seen after partial DA 
depletion in adults 3~. 
A question that remains to be answered, is whether the 
residual capacity of striatal DA neurons contribute 
significantly to the sparing of funclion seen after a 
neonatal 6-OHDA lesion. There are several lines of 
evidence which suggest residual dopaminergic activity is 
important. First, there is evidence showing that in adult 
animals given a partial 6 -OHDA lesion presynaptic 
changes in the remaining DA terminals are crucial for 
recovery of function 47s7. For example, inhibition of DA 
synthesis with a-methyl-p-tyrosine reinstates feeding def- 
icits in recovered rats with a 6 -OHDA lesion ss. Second, 
there is reason to believe that the extracellular concen- 
trations of DA reported here should be sufficient to 
maintain some level of normal function. This is supported 
by studies in adults showing that lesions sparing even a 
small fraction ( - 5 % )  of the DA innervation to the 
striatum fail to produce pronounced behavioral deficits 5~. 
In addition, studies with intracerebral fetal substantia 
nigra or adrenal medulla grafts have shown that replace- 
ment of only a very small fraction of the normal 
complement of DA is sufficient to restore some 
function ~,~. 
The most convincing evidence, however, comes from 
a recent study on the effects of a second 6 -OHDA lesion 
in adulthood on the behavior of rats previously given 
6-OHDA as neonates 32. Rogers and Dunnett 32 report 
that of 21 rats given neonatal 6-OHDA,  and then a 
second 6-OHDA lesion as adults, 16 (76%) became 
severely aphagic and adipsic after the adult lesion, and 15 
of these died within 13 days. Five of the 21 rats were able 
to maintain their body weight by 13 days after the adult 
lesion, but one of these had an incomplete lesion. Thus, 
a second 6-OHDA lesion given in adulthood to rats 
previously depleted of DA as neonates produced the 
adult syndrome of aphagia and adipsia, suggesting that in 
most of the animals residual dopaminergic activity was 
involved in the sparing of these functions subsequent to 
the neonatal lesion. 
If residual DA neurons do contribute to the sparing of 
function seen after neonatal DA depletion, it is clear that 
at best they are able to provide only incomplete protec- 
tion. Although rats given neonatal 6 -OHDA are not 
aphagic, adipsic or akinetic they do show deficits in their 
ability to respond to a variety of regulatory challenges 9'4~. 
Furthermore, there are a number of sensory, motor and 
cognitive functions that are not appreciably spared 
following neonatal DA depletion. For example, deficits 
have been described in tests of spatial navigation ability, 
skilled forepaw use, limb posture 53, spatial alternation 13, 
rapid operant performance in a self-stimulation 
paradigm 45, and a variety of other sensorimotor and 
attentional functions 3~. It is particularly important to 
note that there is a significant positive correlation 
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be tween the magni tude  of  the striatal deplet ion and the 
magni tude  of  the behaviora l  impai rment  seen in many of 
these tasks 33'53. It is possible,  therefore ,  that  the inabili ty 
of these animals to respond to various homeosta t ic  
challenges,  or  the demands  of various test situations, 
could be re la ted  to their  inabil i ty to fur ther  increase D A  
release in response to increased demand,  as i l lustrated 
here by their  failure to respond to an amphetamine  
challenge.  
It must  be emphas ized  here that there is also evidence 
to suggest that the sparing of function seen after neonata l  
D A  deple t ion  is not due to residual dopaminergic  
activity. Rats  deple ted  of D A  as neonates  have been 
shown, in adul thood,  to be insensitive to D A  receptor  
antagonists .  For  example ,  a dose of ha loper idol  that 
significantly depresses  motor  activity in control  animals 
has no effect on neonata l ly  dep le ted  rats tested as adults  s. 
In addi t ion,  p imozide  is less effective in depressing lateral  
hypotha lamic  self-st imulation in neonatal ly  dep le ted  rats 
than in controls  45. This is in contrast  to reports  that 
recovered  animals dep le ted  of D A  in adul thood are very 
sensitive to D A  antagonists ,  which quickly reinstate 
deficits ~8"5s. A comparison of the effects of D A  receptor  
antagonists  in adul t  and neonata l ly  dep le ted  rats suggests 
that  the mechanisms responsible  for recovery of function 
in adults  differ from those responsible for sparing of 
function in neonates .  
Fol lowing neonata l  D A  deplet ion 5-HT levels are 
marked ly  e levated in the str iatum 22~42'43, which has led to 
the suggestion that 5-HT neurons may be involved in 
sparing of function. Consistent  with this hypothesis ,  we 
found that neonata l ly  deple ted  rats showed increased 
extracel lular  concentra t ions  of 5 - H I A A  and increased 
pos t -mor tem tissue concentrat ions  of 5-HT and 5 - H I A A .  
However ,  more  recent  tests of this hypothesis  have failed 
to suppor t  it 6. For  example ,  deple t ion  of 5-HT does not 
prevent  the sparing of function seen after neonatal  
6 - O H D A  t rea tment .  Fur the rmore ,  Whishaw et al. 53 have 
repor ted  that  in neonata l ly  deple ted  rats there is a 
negat ive,  ra ther  than a posit ive,  correlat ion between 
pos t -mor tem tissue concentra t ions  of 5-HT and behav- 
ioral deficits in a variety of behavioral  tasks. Therefore ,  
it seems that  the well documented  increase in serotonin-  
ergic innervat ion of the s t r ia tum which occurs following 
early damage to dopaminergic  systems is not  responsible 
for sparing of function. 
It is worth noting that we did not find a significant 
increase in D A  release associated with conveyor  belt 
walking, al though D A  metabol i sm was increased in the 
neonatal ly  dep le ted  group.  Others  have repor ted  that 
dopaminergic  activity is e levated  in animals t rained to 
walk in circles 36"4855, or  forward on a conveyor  belt 16. 
Freed  and Yamamoto  16 found that  conveyor  belt  walking 
produced  a much larger  increase in D A  metabol ism in 
the nucleus accumbens than in the caudate ,  and in fact, 
the change in caudate  D A  content  was only significant 
when animals walked at the fastest speeds they tested 
(800 cm/min).  In the present  exper iment  animals walked 
at only 300 cm/min, which may explain the lack of effect 
on striatal D A  release. Perhaps  dialysis samples  obta ined  
from the nucleus accumbens would show more pro-  
nounced changes in association with speed of walking 16. 
In conclusion, it is not clear what  kinds of neuroplast ic  
adapta t ions  are responsible  for the sparing of function 
observed after damage to dopaminergic  systems early in 
life. On one hand,  residual D A  neurons may be involved, 
as is the case in animals dep le ted  of D A  in adul thood.  
This idea is suppor ted  by the results repor ted  here,  which 
establish that the extracel lular  concentra t ions  of D A  in 
neonatal ly  dep le ted  rats are much higher than would be 
predic ted  by the ext remely  low concentra t ions  of D A  in 
pos t -mor tem tissue; and,  by the observat ion that a 
second 6 - O H D A  lesion in adu l thood  produces  severe 
aphagia and adipsia in most animals ~2. On the other  
hand,  residual D A  activity may not be involved,  as 
indicated by reports  that  animals dep le ted  of D A  as 
neonates  are subsensit ive to direct-act ing D A  receptor  
antagonists  8"45. Fur ther  studies will be required to dis- 
tinguish between these two possibili t ies.  
Acknowledgements.  This research was conducted while E. Casta- 
fieda was an Albert Heritage Foundation for Medical Research 
Fellow. The research was supported by a grant from the Natural 
Sciences and Engineering Research Council of Canada for the 
HPLC equipment to I.Q.W. and from the Medical Research Council 
of Canada for operating expenses to I.Q.W.T.E.R. was supported 
by a Research Career Development Award from NINCDS and 
Grant 04294 from NIDA. 
REFERENCES 
1 Acheson, A.L. and Zigmond, M.J., Short and long term changes 
in tyrosine hydroxylase activity in rat brain after subtotal 
destruction of central noradrenergic neurons, J. Neurosci., 1 
(1981) 493-5t)4. 
2 Agid, Y., Javoy, F. and Glowinski, J., Hyperactivity of remain- 
ing dopaminergic neurones after partial destruction of the 
nigro-striatal dopaminergic system in the rat, Nature, New Biol., 
245 (1973) 150-151. 
3 Altar, C.A.. Marien, M.R. and Marshall, J.F., Time course of 
adaptions in dopamine biosynthesis, metabolism, and release 
following nigrostriatal lesions: implications for behavioral recov- 
ery from brain injury, J. Neurochem.,  48 (1987) 390-399. 
Bernheimer, H., Birkmayer, W., Hornykiewicz, O., Jellinger, 
K. and Seitelberger, F., Brain dopamine and the syndromes of 
Parkinson and Huntington - -  clinical, morphological and neu- 
rochemical correlations, J. Neurol. Sci., 20 (1973) 415-455. 
Breese, G.R., Baumeister, A.A., McCown, T.J., Emerick, 
G.D., Frye, G.D., Crotty, K. and Muller, R.A., Behavioral 
differences between neonatal and adult 6-hydroxydopamine- 
treated rats to dopamine agonists: relevance to neurological 
38 
symptoms in clinical syndromes with reduced brain dopamine, J. 
Pharmacol. Exp. Ther., 231 (1984) 343-354. 
6 Bruno, J.P., Jackson, D., Zigmond, M.J. and Stricker, E.M., 
Effect of dopamine-depleting brain lesions in rat pups: role of 
striatal serotonergic neurons in behavior. Behav. Neurosci., 101 
(1987) 812-818. 
7 Bruno, J.P., Snyder, A.M. and Stricker, E.M., Effect of 
dopamine-depleting brain lesions on suckling and weaning in 
rats, Behav. Neurosci., 98 (1984) 156-161. 
8 Bruno, J.P., Stricker, E.M. and Zigmond, M.J., Rats given 
dopamine-depleting lesions as neonates are subsensitive to 
dopaminergic antagonists as adults, Behav. Neurosci., 99 (1985) 
771-775. 
9 Bruno, J.P., Zigmond, M.J. and Stricker, E.M., Rats given 
dopamine-depleting lesions as neonates do not respond to acute 
homeostatic imbalances as adults, Behav. Neurosci., 100 (1986) 
126-128. 
10 Creese, I., Burt, D.R. and Snyder, S.H., Dopamine receptor 
binding enhancement accompanies lesion-induced behavioral 
sensitivity, Science, 197 (1977) 596-598. 
11 Dunnett, S.B., Bj6rklund, A., Gage, EH. and Stenevi, U., 
Transplantation of mesencephalic dopamine neurons to the 
striatum of adult rats. In A. Bjfrklund and U. Stenevi (Eds.), 
Neural Grafting in the Mammalian CNS, Elsevier, Amsterdam, 
1985, pp. 451-469. 
12 Erinoff, L., MacPhail, R.C., Heller, A. and Selden, L.S., 
Age-dependent effects of 6-hydroxydopamine on locomotor 
activity in the rat, Brain Research, 164 (1979) 195-205. 
13 Feeser, H.R. and Raskin, L.A., Effects of neonatal dopamine 
depletion on spatial ability during ontogeny, Behav. Neurosci., 
101 (1987) 812-818. 
14 Feltz, P. and De Clamplain, J., Enhanced sensitivity of caudate 
neurones to microiontophoretic injections of dopamine in 
6-hydroxydopamine treated cats, Brain Research, 43 (1972) 
601-605. 
15 Freed, W.J., Functional brain tissue transplantation: reversal of 
lesion induced rotation by intraventricular substantia nigra and 
adrenal medulla grafts, with a note on intracranial retinal grafts, 
Biol. Psychiatry, 18 (1983) 1205-1267. 
16 Freed, C.R. and Yamamoto, B.K., Regional brain dopamine 
metabolism: a marker for the speed, direction, and posture of 
moving animals, Science, 229 (1985) 62-65. 
17 Heffner, T.G., Hartman, J.A. and Seiden, L.S., A rapid method 
for the regional dissection of the rat brain, Pharmacol. Biochem. 
Behav., 13 (1980) 453-456. 
18 Heffner, T.G., Zigmond, M.J. and Stricker, E.M., Effects of 
dopaminergic agonists and antagonists on feeding in intact and 
6-hydroxydopamine rats, J. Pharmacol. Exp. Ther., 201 (1977) 
386-399. 
19 Hefti, E,  Enz, A. and Melamed, E., Partial lesions of the 
nigrostriatal pathway in the rat-acceleration of transmitter 
synthesis and release of surviving dopaminergic neurones by 
drugs, Neuropharmacology, 24 (1985) 19-23. 
20 Hefti, F., Melamed, E. and Wurtman, R.J., Partial lesions of the 
dopaminergic nigrostriatal system in rat brain: biochemical 
characterization, Brain Research, 195 (1980) 123-137. 
21 Hornykiewicz, O., Dopamine and extrapyramidat motor func- 
tion and dysfunction. In Research Publications of the Association 
.for Research in Nervous and Mental Disease, Vol. 50, Williams 
and Wilkins, Baltimore, 1972, pp. 390-415. 
22 Mailman, R.B., Towle, A., Schulz, D.A., Lewis, M.H., Breese, 
G.R., DeHaven, D.L. and Krigman, M.R., Neonatal 6-OHDA 
treatment of rats: changes in dopamine (LDA) receptors, striatal 
neurochemistry and anatomy, Soc. Neurosci. Abstr., 9 (1983) 
932. 
23 Marshall, J .E,  Brain function: neural adaptations and recovery 
from injury, Annu. Rev. Psychol., 35 (1984) 277-308. 
24 Marshall, J.F., Richardson, J.S. and Teitelbaum, P., Nigrostri- 
atal bundle damage and the lateral hypothalamic syndrome, J. 
Comp. Physiol. Psychol.. 87 (1974)808-830. 
25 Martin, J.P., The Basal Ganglia and Posture, Pitman, London, 
1967. 
26 Mishra, R.K., Gardner, E.L., Katzman, R. and Makman, 
M.H., Enhancement of dopamine-stimulated adenylate cyclase 
activity in rat caudate after lesions in the substantia nigra: 
evidence for denervation supersensitivity, Proc. Natl. Acad; Sci. 
U.S.A., 71 (1974) 3883-3887. 
27 Neve, K.A., Kozlowski, M.R. and Marshall, J.F., Plasticity of 
neostriatal dopamine receptors after nigrostriatal injury: rela- 
tionship to recovery of sensorimotor functions and behavioral 
supersensitivity, Brain Research, 244 (1982) 33-44. 
28 Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic 
Coordinates, 2nd edn., Academic, New York, 1986. 
29 Raskin, L.A., Schaywitz, B.A., Anderson, G.M., Cohen, D.J., 
Teicher, M.H. and Linakis, J., Differential effects of selective 
dopamine, norepinephrine or catecholamine depletions on ac- 
tivity and learning in the developing rat. Pharmacol. Biochem. 
and Behav., 19 (1983) 743-749. 
30 Robinson, T.E., Becker, J.B., Young, E.A., Akil, H. and 
Castafieda, E., The effects of footshock stress on regional brain 
dopamine metabolism and pituitary fl-endorphin release in rats 
previously sensitized to amphetamine, Neuropharmacology, 26 
(1987) 679-691. 
31 Robinson, T.E. and Whishaw, I.Q., Normalization of extracel- 
lular dopamine in striatum following recovery from a partial 
unilateral 6-OHDA lesion of the substantia nigra: a microdialysis 
study in freely moving rats, Brain Research, 450 (1988) 209-224. 
32 Rogers, D.C. and Dunnett, S.B., Neonatal dopamine-rich grafts 
and 6-OHDA lesions independently provide partial protection 
from the adult nigrostriatal lesion syndrome, Behav. Brain Res., 
34 (1989) 131-146. 
33 Schallert, T., Petrie, B.E and Whishaw, I.Q., Unspaired 
sensorimotor and attentional disorders following neonatal 
striatal dopamine depletion, Psychobiol., in press. 
34 Schallert, T., Whishaw, I.Q., Ramirez, V.D. and Teitelbaum, P., 
Compulsive, abnormal walking caused by anticholinergics in 
akinetic, 6-hydroxydopamine-treated rats, Science, 199 (1978) 
1461-1463. 
35 Schallert, T., Whishaw, I.Q., Ramirez, V.D. and Teitelbaum, P., 
The postures of catecholamine depletion catalepsy: their possi- 
ble adaptive value in thermoregulation, Physiol. Behav., 21 
(1978) 817-820. 
36 Schwarting, R. and Huston, J.P., Dopamine and serotonin 
metabolism in brain sites ipsi- and contralateral to direction of 
conditioned turning in rats, J. Neurochem., 48 (1987) 1473-1479. 
37 Schultz, W., Depletion of dopamine in the striatum as an 
experimental model of Parkinsonism: direct effects and adaptive 
mechanisms, Prog. Neurobiol., 18 (1982) 121-166. 
38 Sharman, D.F., Poirier, L.J., Murphy, G.E and Sourkes, T.L., 
Homovanillic acid and dihydroxyphenylacetic acid in the stri- 
atum of monkeys with brain lesions, Can. J. Physiol. Pharma- 
col., 45 (1967) 57-62. 
39 Shaywitz, B.A., Klopper, J.H., Yager, R.D. and Gordon, J.W., 
Paradoxical response to amphetamine in developing rats treated 
with 6-hydroxydopamine, Nature (Lond.), 261 (1976) 153-155. 
40 Shaywitz, B.A., Yager, R.D. and Klopper, J.H., Selective brain 
dopamine depletion in developing rats: an experimental model 
of minimal brain dysfunction, Science, 191 (1976) 305-308. 
41 Smith, R.D., Cooper, B.R. and Breese, G.R., Growth and 
behavioral changes in developing rats treated intracisternally 
with 6-hydroxydopamine: evidence for involvement of brain 
dopamine, J. Pharmacol. Exp. Ther., 1985 (1973) 609-619. 
42 Snyder, A.M., Zigmond, M.J. and Lund, R.D., Sprouting of 
serotoninergic afferents into striatum after dopamine-depleting 
lesions in infant rats: a retrograde transport and immunocyto- 
chemical study, J. Comp. Neurol., 245 (1986) 274-281. 
43 Stachowiak, M.K., Bruno, J.P., Snyder, A.M,, Stricker, E.M. 
and Zigmond, M.J., Apparent sprouting of striatal serotonergic 
terminals after dopamine-depteting lesions in neonatal rats, 
Brain Research, 291 (1984) 164-167. 
39 
44 Stachowiak, M.K., Keller. R.W., Stricker, E.M. and Zigmond, 
M.J., Increased dopamine effiux from striatal slices during 
development and after nigrostriatal bundle damage, J. Neuro- 
sci., 7 (1987) 1648-1654. 
45 Stellar, J.R., Waraczynski, M. and Bruno, J.P., Neonatal 
dopamine depletions spare lateral hypothalamic stimulation 
reward in adult rats, Pharmacol. Biochem. Behav., 30 (1988) 
365-370. 
46 Stricker, E.M. and Zigmond, M.J., Effects on homeostasis of 
intraventricular injections of 6-hydroxydopamine in rats, J. 
Comp. Physiol. Psychol., 86 (1974) 973-994. 
47 Stricker, E.M. and Zigmond, M.J., Recovery of function after 
damage to central catecholamine-containing neurons: a neuro- 
chemical model for the lateral hypothalamic syndrome. In J.M. 
Sprague and A.N. Epstein (Eds.), Progress in Psychobiology 
and Physiological Psychology, Vol. 6, Academic, New York, 
1976, pp. 121-189. 
48 Szostak, C., Jukubovic, A., Phillips, A.G. and Fibiger, H.C., 
Bilateral augmentation of dopaminergic and serotonergic activ- 
ity in striatum and nucleus accumbens induced by conditioned 
circling, J. Neurosci., 6 (1986) 2037-2044. 
49 Thornburg, J.E. and Moore, K.E., Supersensitivity to dopamine 
agonists following unilateral, 6-hydroxydopamine-induced 
striatal lesions in mice, J. Pharmacol. Exp. Ther., 192 (1975) 
42-49. 
50 Ungerstedt, U., Adipsia and aphagia after 6-hydroxydopamine 
induced degeneration of the nigrostriatal dopamine system, Acta 
Physiol. Scand., 82 (1971) 96-122. 
51 Ungerstedt, U., Measurement of neurotransmitter release by 
intracranial dialysis. In C.A. Marsden (Ed.), Measurement of 
Neurotransmitter Release In Vivo, Wiley, New York, 1984, pp. 
81-105. 
52 Whishaw, I.Q. and Dunnett,  S.B., Dopamine depletion, stim- 
ulation or blockade in the rat disrupts spatial navigation and 
locomotion dependent upon beacon or distal cues, Behav, Brain 
Res.. 18 (1985) 11-29. 
53 Whishaw, I.Q., Funk, D.R., Hawryluk, S.J. and Karbashewski, 
E.D., Absence of sparing of spatial navigation, skilled forelimb 
and tongue use and limb posture in the rat after neonatal 
dopamine depletion, Physiol. Behav., 40 (1987) 247-253. 
54 Whishaw, I.Q., Robinson, T.E., Schallert, T., DeRyck, M. and 
Ramirez, V.D., Electrical activity of the hippocampus and 
neocortex in rats depleted of brain dopamine and norepineph- 
fine: relations to behavior and effects of atropine, Exp. Neurol., 
62 (1978) 748-767. 
55 Yamamoto, B.K., Lane, R.K and Freed, C.R., Normal rats 
trained to circle show asymmetric caudate dopamine release, 
LiJ? Sci., 30 (1982) 2155-2162. 
56 Zigmond, MJ . ,  Acheson, A.L., Stachowiak, M.K. and Stricker, 
E.M., Neurochemical compensation after nigrostriatal bundle 
injury in an animal model of preclinical parkinsonism, Arch. 
Neurol., 41 (1984) 856-861. 
57 Zigmond, M.J., Stachowiak, M.K., Berger, T.W. and Stricker, 
E.M., Neurochemical events underlying continued function 
despite injury to monoaminergic systems, Exp. Brain Res., 
Suppl. 13 (1986) 119-128. 
58 Zigmond, M.J. and Stricker, E.M., Recovery of feeding and 
drinking by rats after intraventricular 6-hydroxydopamine or 
lateral hypothalamic lesions, Science, 1982 (1973) 717-720. 
59 Zis, A.P., Fibiger, H.C. and Phillips, A.G.,  Reversal by L-dopa 
of impaired learning clue to destruction of the dopaminergic 
nigrostriatal projection, Science, 1985 (1974) 960-962. 
Note added in proof 
The suggestion here that the relatively high extracellular concentrations of DA may be important for sparing of function in rats previously 
depleted of DA as neonates is supported in a recent paper by D.C. Rogers and S.B. Dunnett (Neurosci. Lett., 102 (1989) 108-113). These 
authors have shown that behavioral recovery of rats receiving neonatal 6-OHDA lesions is mediated by residual catecholamines because doses 
of a-methyl-p-tyrosine that were ineffective in control animals disrupted feeding in neonatally depleted animals. 
